Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...

Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with ...

Nvidia and Eli Lilly's AI tie-up shows drug discovery emerging as a new ETF growth theme across semiconductors and health ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

What happens when machines don’t just help humans, but surpass them at the most delicate, high-stakes task imaginable? Elon ...

The Global Agtech and Advanced Food Technologies Market Report 2026-2036 reveals promising growth opportunities in vertical farming, smart farming, and alternative proteins, driven by population ...

NantWorks, LLC, and ImmunityBio, Inc. (NASDAQ: IBRX), today announced the inaugural U.S.-Saudi Biotech Alliance Summit, to be ...

If someone orders shapewear from Spanx LLC’s website today, a humanoid robot handles that package. At a GXO Logistics Inc. distribution center in Georgia, Agility Robotics Inc.’s bipedal machines move ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

Gilead Sciences, Inc. (NASDAQ:GILD), headquartered in Foster City, California, continues to lead in antiviral and oncology therapies while advancing next-generation biologics through AI integration.

A few short months ago, almost every robot made by the hundreds of companies working on humanoid robots could charitably be described as slow, topping out at around three mph. Walking was on the edge ...

The artificial intelligence sector continues to attract substantial investment across various stages of funding, from seed to Series B, despite some broader market uncertainties. The past week has ...